Fed Ghali

Fed Ghali, MD, is an Assistant Professor of Urology at the Yale School of Medicine, specializing in urologic oncology with expertise in bladder, ureter, kidney, and testicular cancers. He holds affiliations with Yale Cancer Center, Prostate & Urologic Cancers Program, and Urologic Oncology at Yale School of Medicine. Ghali completed his medical degree at Geisel School of Medicine, residency in Urology at UC San Diego, and a Society of Urologic Oncology fellowship at the University of Washington.

His research focuses on clinical trial design, biomarker development for bladder cancer, and improving patient outcomes through personalized therapy. Notable interests include non-muscle invasive bladder cancer recurrence detection via urinary DNA analysis and optimizing treatment protocols for variant histology cancers. He collaborates with institutions nationally to advance therapeutic strategies and biomarker discovery.

Ghali emphasizes patient-centered care, balancing high-volume clinical practice with compassionate individualized treatment. He actively participates in Yale's translational research initiatives and clinical trials to bring cutting-edge therapies to patients. His work highlights the integration of surgical innovation, molecular diagnostics, and clinical research in oncology.